GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited received ANDA approval for Sildenafil for oral suspension.03-12-2023
03-12-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited received ANDA approval for Sildenafil for oral suspension.03-12-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst/ Investor Meet27-11-2023
GRANULES INDIA LTD.-$ - 532482 - Disclosure Of Information Under The Regulation 30 Of The SEBI (LODR) Regulations, 2015
Disclosure of information under the Regulation 30 of the SEBI (LODR) Regulations, 201523-11-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Earnings conference call for Q2 of FY2416-11-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting16-11-2023
Buy Granules India; target of Rs 417 Sharekhan
Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 417 in its research report dated November 09, 2023.13-11-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the Earnings Conference call for Q2 and half year of FY24.09-11-2023
GRANULES INDIA LTD.-$ - 532482 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure of Related Party Transaction for the half year ended on September 30, 202309-11-2023